348 related articles for article (PubMed ID: 30713036)
1. Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study.
Downing A; Wright P; Hounsome L; Selby P; Wilding S; Watson E; Wagland R; Kind P; Donnelly DW; Butcher H; Catto JWF; Cross W; Mason M; Sharp L; Weller D; Velikova G; McCaughan E; Mottram R; Allen M; Kearney T; McSorley O; Huws DW; Brewster DH; McNair E; Gavin A; Glaser AW
Lancet Oncol; 2019 Mar; 20(3):436-447. PubMed ID: 30713036
[TBL] [Abstract][Full Text] [Related]
2. Fifteen year quality of life outcomes in men with localised prostate cancer: population based Australian prospective study.
Mazariego CG; Egger S; King MT; Juraskova I; Woo H; Berry M; Armstrong BK; Smith DP
BMJ; 2020 Oct; 371():m3503. PubMed ID: 33028540
[TBL] [Abstract][Full Text] [Related]
3. Regional Variations in Quality of Survival Among Men with Prostate Cancer Across the United Kingdom.
Donnelly DW; Gavin A; Downing A; Hounsome L; Kearney T; McNair E; Allan D; Huws DW; Wright P; Selby PJ; Kind P; Watson E; Wagland R; Wilding S; Butcher H; Mottram R; Allen M; McSorley O; Sharp L; Mason MD; Cross WR; Catto JWF; Glaser AW
Eur Urol; 2019 Aug; 76(2):228-237. PubMed ID: 31060822
[TBL] [Abstract][Full Text] [Related]
4. Quality of life among symptomatic compared to PSA-detected prostate cancer survivors - results from a UK wide patient-reported outcomes study.
Donnelly DW; Vis LC; Kearney T; Sharp L; Bennett D; Wilding S; Downing A; Wright P; Watson E; Wagland R; Cross WR; Mason MD; Siesling S; van Manen JG; Glaser AW; Gavin A
BMC Cancer; 2019 Oct; 19(1):947. PubMed ID: 31615476
[TBL] [Abstract][Full Text] [Related]
5. Effect of investigation intensity and treatment differences on prostate cancer survivor's physical symptoms, psychological well-being and health-related quality of life: a two country cross-sectional study.
Gavin AT; Donnelly D; Donnelly C; Drummond FJ; Morgan E; Gormley GJ; Sharp L
BMJ Open; 2016 Dec; 6(12):e012952. PubMed ID: 27993906
[TBL] [Abstract][Full Text] [Related]
6. Patient activation and patient-reported outcomes of men from a community pharmacy lifestyle intervention after prostate cancer treatment.
Lemanska A; Poole K; Manders R; Marshall J; Nazar Z; Noble K; Saxton JM; Turner L; Warner G; Griffin BA; Faithfull S
Support Care Cancer; 2022 Jan; 30(1):347-358. PubMed ID: 34286350
[TBL] [Abstract][Full Text] [Related]
7. Quality of Life After Bladder Cancer: A Cross-sectional Survey of Patient-reported Outcomes.
Catto JWF; Downing A; Mason S; Wright P; Absolom K; Bottomley S; Hounsome L; Hussain S; Varughese M; Raw C; Kelly P; Glaser AW
Eur Urol; 2021 May; 79(5):621-632. PubMed ID: 33581875
[TBL] [Abstract][Full Text] [Related]
8. Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life.
Lane A; Metcalfe C; Young GJ; Peters TJ; Blazeby J; Avery KN; Dedman D; Down L; Mason MD; Neal DE; Hamdy FC; Donovan JL;
BJU Int; 2016 Dec; 118(6):869-879. PubMed ID: 27415448
[TBL] [Abstract][Full Text] [Related]
9. Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study.
Ahmed HU; Hindley RG; Dickinson L; Freeman A; Kirkham AP; Sahu M; Scott R; Allen C; Van der Meulen J; Emberton M
Lancet Oncol; 2012 Jun; 13(6):622-32. PubMed ID: 22512844
[TBL] [Abstract][Full Text] [Related]
10. Urinary, bowel and sexual health in older men from Northern Ireland.
Donnelly DW; Donnelly C; Kearney T; Weller D; Sharp L; Downing A; Wilding S; Wright P; Kind P; Catto JWF; Cross WR; Mason MD; McCaughan E; Wagland R; Watson E; Mottram R; Allen M; Butcher H; Hounsome L; Selby P; Huws D; Brewster DH; McNair E; Rivas C; Nayoan J; Horton M; Matheson L; Glaser AW; Gavin A
BJU Int; 2018 Nov; 122(5):845-857. PubMed ID: 29489050
[TBL] [Abstract][Full Text] [Related]
11. Influence of deprivation and rurality on patient-reported outcomes of men living with and beyond prostate cancer diagnosis in the UK: A population-based study.
Smith L; Downing A; Norman P; Wright P; Hounsome L; Watson E; Wagland R; Selby P; Kind P; Donnelly DW; Butcher H; Huws D; McNair E; Gavin A; Glaser AW
Cancer Epidemiol; 2020 Dec; 69():101830. PubMed ID: 33002843
[TBL] [Abstract][Full Text] [Related]
12. Patient-reported outcomes following abiraterone acetate plus prednisone added to androgen deprivation therapy in patients with newly diagnosed metastatic castration-naive prostate cancer (LATITUDE): an international, randomised phase 3 trial.
Chi KN; Protheroe A; Rodríguez-Antolín A; Facchini G; Suttman H; Matsubara N; Ye Z; Keam B; Damião R; Li T; McQuarrie K; Jia B; De Porre P; Martin J; Todd MB; Fizazi K
Lancet Oncol; 2018 Feb; 19(2):194-206. PubMed ID: 29326030
[TBL] [Abstract][Full Text] [Related]
13. Patient-Reported Functional Outcomes After Hypofractionated or Conventionally Fractionated Radiation for Prostate Cancer: A National Cohort Study in England.
Nossiter J; Sujenthiran A; Cowling TE; Parry MG; Charman SC; Cathcart P; Clarke NW; Payne H; van der Meulen J; Aggarwal A
J Clin Oncol; 2020 Mar; 38(7):744-752. PubMed ID: 31895608
[TBL] [Abstract][Full Text] [Related]
14. Symptoms, unmet needs, psychological well-being and health status in survivors of prostate cancer: implications for redesigning follow-up.
Watson E; Shinkins B; Frith E; Neal D; Hamdy F; Walter F; Weller D; Wilkinson C; Faithfull S; Wolstenholme J; Sooriakumaran P; Kastner C; Campbell C; Neal R; Butcher H; Matthews M; Perera R; Rose P
BJU Int; 2016 Jun; 117(6B):E10-9. PubMed ID: 25818406
[TBL] [Abstract][Full Text] [Related]
15. Symptom and function profiles of men with localized prostate cancer.
Reeve BB; Tan X; Chen RC; Usinger DS; Pinheiro LC
Cancer; 2018 Jul; 124(13):2832-2840. PubMed ID: 29660795
[TBL] [Abstract][Full Text] [Related]
16. Cancer-related symptoms, mental well-being, and psychological distress in men diagnosed with prostate cancer treated with androgen deprivation therapy.
Wilding S; Downing A; Wright P; Selby P; Watson E; Wagland R; Donnelly DW; Hounsome L; Butcher H; Mason M; Henry A; Gavin A; Glaser AW
Qual Life Res; 2019 Oct; 28(10):2741-2751. PubMed ID: 31115843
[TBL] [Abstract][Full Text] [Related]
17. Decision regret in men living with and beyond nonmetastatic prostate cancer in the United Kingdom: A population-based patient-reported outcome study.
Wilding S; Downing A; Selby P; Cross W; Wright P; Watson EK; Wagland R; Kind P; Donnelly DW; Hounsome L; Mottram R; Allen M; Kearney T; Butcher H; Gavin A; Glaser A
Psychooncology; 2020 May; 29(5):886-893. PubMed ID: 32065691
[TBL] [Abstract][Full Text] [Related]
18. Predictors of multidomain decline in health-related quality of life after stereotactic body radiation therapy (SBRT) for prostate cancer.
Dess RT; Jackson WC; Suy S; Soni PD; Lee JY; Abugharib AE; Zumsteg ZS; Feng FY; Hamstra DA; Collins SP; Spratt DE
Cancer; 2017 May; 123(9):1635-1642. PubMed ID: 28001303
[TBL] [Abstract][Full Text] [Related]
19. Long-term quality of life in disadvantaged men with prostate cancer on androgen-deprivation therapy.
Sevilla C; Maliski SL; Kwan L; Connor SE; Litwin MS
Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):237-43. PubMed ID: 22289781
[TBL] [Abstract][Full Text] [Related]
20. Expanded Prostate Cancer Index Composite versus Incontinence Symptom Index and Sexual Health Inventory for Men to measure functional outcomes after prostatectomy.
Hedgepeth RC; Labo J; Zhang L; Wood DP
J Urol; 2009 Jul; 182(1):221-7; discussion 227-8. PubMed ID: 19450842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
